Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cosmo, S. D.
Right arrow Articles by Trischitta, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosmo, S. D.
Right arrow Articles by Trischitta, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1402-1407
© 2002 European Renal Association-European Dialysis and Transplant Association

The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression

Salvatore De Cosmo1,, Giuseppe Miscio1, Luigi Zucaro1, Maurizio Margaglione2, Alessandra Argiolas1, Stephen Thomas3, Giampiero Piras4, Roberto Trevisan5, Paolo Cavallo Perin6, Simonetta Bacci1, Lucia Frittitta7, Antonio Pizzuti1, Vittorio Tassi1, Giovanni Di Minno2, Giancarlo Viberti3 and Vincenzo Trischitta1,8

1 Unit of Endocrinology and 2 Unit for Atherosclerosis and Thrombosis, Scientific Institute ‘Casa Sollievo della Sofferenza’ San Giovanni Rotondo (FG), Italy, 3 Unit for Metabolic Medicine, KCL School of Medicine, Guy's Hospital, London, UK, 4 Diabetes Unit, Hospital ‘Brotzu’, Cagliari, Italy, 5 Chair of Metabolic Medicine, Padua, Italy, 6 Institute of Internal Medicine, Turin, Italy, 7 Institute of Internal Medicine, Endocrine and Metabolic Disease, University of Catania, Garibaldi Hospital, Catania, Italy and 8 Department of Clinical Science, University "La Sapienza", Rome, Italy

Background. The DD genotype of the ACE gene predisposes to faster diabetic nephropathy (DN) progression but its role in DN development is more controversial. We reported previously, in type 1 diabetic patients, an association between faster DN progression and the PC-1 gene Q121 variant, which associates with insulin resistance in non-diabetic subjects. We investigated here whether the combination of the ACE DD genotype and the PC-1 Q121 variant predicts the development and/or progression of DN in type 1 diabetic patients.

Methods. Type 1 diabetic patients either with (n=159) or without (n=122) nephropathy were evaluated in a cross-sectional study. DN was defined as the presence of microalbuminuria or persistent proteinuria in a subject with more than 10-year duration of disease and concomitant diabetic retinopathy, and with no evidence of heart failure or other renal disease. Seventy-five (47 male/28 female) type 1 diabetic patients with nephropathy in whom retrospective information with repeated measurements of serum creatinine was available, were analysed in a longitudinal study.

Results. No association of the PC-1 Q121 variant and the ACE D/D genotype with DN development was observed. However, the ACE DD genotype and the PC-1 Q121 variant were associated, both independently (P=0.02 and P=0.025, respectively) or in combination (P=0.02), with a faster rate of glomerular filtration rate decline. An interaction (P=0.03) was observed between the two genes in increasing the individual patient's risk of being a fast progressor.

Conclusion. Our data suggest that, in type 1 diabetic patients, the ACE and the PC-1 genes interact in increasing the individual risk of having a faster DN progression.

Keywords: albuminuria; end-stage renal failure; gene–gene interaction; gene polymorphism; type 1 diabetes

Correspondence and offprint requests to: Dr Salvatore De Cosmo, Unit of Endocrinology, IRCCS ‘Casa Sollievo della Sofferenza’, I-71013 San Giovanni Rotondo (FG), Italy. Email: endocrinologia{at}operapadrepio.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman
Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test
Diabetes, November 1, 2005; 54(11): 3305 - 3318.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. K. Jacobsen
Preventing end stage renal disease in diabetic patients -- genetic aspect (part I)
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2005; 6(1): 1 - 14.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. A. Young, W. J. Katon, M. Von Korff, G. E. Simon, E. H. B. Lin, P. S. Ciechanowski, T. Bush, M. Oliver, E. J. Ludman, and E. J. Boyko
Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 219 - 228.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. De Cosmo, R. Trevisan, M. Dalla Vestra, M. Vedovato, A. Argiolas, A. Solini, A. Saller, F. Damone, A. Tiengo, V. Trischitta, et al.
PC-1 Amino Acid Variant Q121 Is Associated With a Lower Glomerular Filtration Rate in Type 2 Diabetic Patients With Abnormal Albumin Excretion Rates
Diabetes Care, October 1, 2003; 26(10): 2898 - 2902.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Marre
A KQ121 variant in the PC-1 gene and diabetic nephropathy: discrepant results between North and South Europe
Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1546 - 1547.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.